{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:05:19Z","timestamp":1790665519000,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,15]]},"DOI":"10.1093\/infdis\/jix265","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T03:11:40Z","timestamp":1496200300000},"page":"254-262","source":"Crossref","is-referenced-by-count":55,"title":["Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy"],"prefix":"10.1093","volume":"216","author":[{"given":"Timothy J","family":"Henrich","sequence":"first","affiliation":[{"name":"Division of Experimental Medicine, University of California, San Francisco;"},{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen S","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, University of California, San Francisco;"},{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hanhauser","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, University of California, San Francisco;"},{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Scully","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"},{"name":"Harvard Medical School, and"},{"name":"Dana-Farber Cancer Institute, Boston,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E","family":"Hogan","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, University of California, San Francisco;"},{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne P","family":"Robles","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn S","family":"Leadabrand","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M","family":"Marty","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"},{"name":"Harvard Medical School, and"},{"name":"Dana-Farber Cancer Institute, Boston,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine D","family":"Palmer","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Jost","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, and"},{"name":"Beth Israel Deaconess Medical Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"K\u00f6rner","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Z","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh T","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Harvard Medical School, and"},{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, and"},{"name":"Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayad","family":"Hamdan","sequence":"additional","affiliation":[{"name":"Harvard Medical School, and"},{"name":"Beth Israel Deaconess Medical Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Abramson","sequence":"additional","affiliation":[{"name":"Harvard Medical School, and"},{"name":"Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S","family":"LaCasce","sequence":"additional","affiliation":[{"name":"Harvard Medical School, and"},{"name":"Dana-Farber Cancer Institute, Boston,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Kuritzkes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,3]]},"reference":[{"key":"key\n\t\t\t\t20180306115537_CIT0001","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm.4108","article-title":"International AIDS Society global scientific strategy: towards an HIV cure 2016","volume":"22","author":"Deeks","year":"2016","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180306115537_CIT0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180306115537_CIT0003","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/518250","article-title":"Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus","volume":"195","author":"Chun","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306115537_CIT0004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","article-title":"Towards an HIV cure: a global scientific strategy","volume":"12","author":"Deeks","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180306115537_CIT0005","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","article-title":"Lymphocyte depletion during treatment with intensive chemotherapy for cancer","volume":"84","author":"Mackall","year":"1994","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306115537_CIT0006","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1182\/blood.V89.10.3700","article-title":"Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy","volume":"89","author":"Mackall","year":"1997","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306115537_CIT0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/stemcells.18-1-10","article-title":"T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review","volume":"18","author":"Mackall","year":"2000","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t20180306115537_CIT0008","first-page":"3936","article-title":"In vitro effects of 4-hydroperoxycyclophosphamide on the morphology and function of human peripheral blood mononuclear phagocytic cells (macrophages)","volume":"44","author":"Jason","year":"1984","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180306115537_CIT0009","first-page":"375","article-title":"The influence of cyclophosphamide on lymph node and peripheral blood lymphocytes in mice","volume":"26","author":"Mackiewicz","year":"1978","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key\n\t\t\t\t20180306115537_CIT0010","first-page":"1559","article-title":"Immune reconstitution in patients wiht B-non Hodgkin lymphoma (B-NHL) treated with rituximab, chemotherapy or both\u2014a cohort study","volume":"95","author":"Afonso","year":"2010","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180306115537_CIT0011","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/annonc\/mdq677","article-title":"Evaluation of the addition of rituximab to CODOX-M\/IVAC for Burkitt\u2019s lymphoma: a retrospective analysis","volume":"22","author":"Barnes","year":"2011","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180306115537_CIT0012","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood-2009-11-253039","article-title":"The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma","volume":"115","author":"Dunleavy","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306115537_CIT0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12185-010-0528-6","article-title":"Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis","volume":"91","author":"Irie","year":"2010","journal-title":"Int J Hematol"},{"key":"key\n\t\t\t\t20180306115537_CIT0014","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306115537_CIT0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200363080-00005","article-title":"Rituximab: a review of its use in non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukaemia","volume":"63","author":"Plosker","year":"2003","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180306115537_CIT0016","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306115537_CIT0017","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials","volume":"105","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306115537_CIT0018","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1200\/JCO.2006.09.0407","article-title":"Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin\u2019s lymphoma","volume":"25","author":"Spina","year":"2007","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180306115537_CIT0019","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1172\/JCI64314","article-title":"Expansion of HIV-specific T follicular helper cells in chronic HIV infection","volume":"122","author":"Lindqvist","year":"2012","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180306115537_CIT0020","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180306115537_CIT0021","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180306115537_CIT0022","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180306115537_CIT0023","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306115537_CIT0024","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306115537_CIT0025","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nprot.2008.108","article-title":"A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load","volume":"3","author":"Malnati","year":"2008","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t20180306115537_CIT0026","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jviromet.2012.08.019","article-title":"Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR","volume":"186","author":"Henrich","year":"2012","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20180306115537_CIT0027","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1128\/JVI.74.18.8541-8549.2000","article-title":"Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay","volume":"74","author":"Altfeld","year":"2000","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180306115537_CIT0028","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180306115537_CIT0029","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20022058","article-title":"Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection","volume":"198","author":"Amyes","year":"2003","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180306115537_CIT0030","doi-asserted-by":"crossref","first-page":"e92118","DOI":"10.1371\/journal.pone.0092118","article-title":"Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy","volume":"9","author":"Cillo","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306115537_CIT0031","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/088922202753747888","article-title":"Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons","volume":"18","author":"Bartlett","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180306115537_CIT0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1469-0691.2007.01895.x","article-title":"Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy","volume":"14","author":"Kuo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180306115537_CIT0033","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jmv.22013","article-title":"High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia","volume":"83","author":"Ogata","year":"2011","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20180306115537_CIT0034","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1128\/JVI.00831-14","article-title":"Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment","volume":"88","author":"Gianella","year":"2014","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180306115537_CIT0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jis777","article-title":"Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA","volume":"207","author":"Gianella","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306115537_CIT0036","unstructured":"Weibel SG , AndersonC, VarSR Detectable CMV in PBMC is associated with slower HIV DNA decay during suppressive ART [abstract 375]. In: Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 13\u201316 February 2017."},{"key":"key\n\t\t\t\t20180306115537_CIT0037","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/JVI.02638-15","article-title":"Replication of human herpesviruses is associated with higher HIV DNA levels during antiretroviral therapy started at early phases of HIV infection","volume":"90","author":"Gianella","year":"2016","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180306115537_CIT0038","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/2\/254\/24264093\/jix265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T01:04:17Z","timestamp":1602205457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/2\/254\/3860643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,3]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6,3]]},"published-print":{"date-parts":[[2017,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix265","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,15]]},"published":{"date-parts":[[2017,6,3]]}}}